Recombinant Human IGFBP-7 protein (His Tag)

ED50

/

Species

Human

Purity

>90 %, SDS-PAGE

GeneID

3490

Accession

Q16270-1

Cat No : Eg0815

Print datasheet

Synonyms

IGFBP7,IBP7,IBP-7,IGF-binding protein 7,IGFBP-7



Technical Specifications

Purity >90 %, SDS-PAGE
Endotoxin Level <1.0 EU/μg protein, LAL method
Biological Activity
Not tested
Source HEK293-derived Human IGFBP-7 protein Ser27-Leu282 (Accession# Q16270-1(K95R))with a His tag at the N-terminus.
Predicted Molecular Mass 27.3 kDa
SDS-PAGE 30-35 kDa, reducing (R) conditions
Formulation Lyophilized from sterile PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

IGFBP7, also named as MAC25, PSF, IBP-7 and TAF,is a member of the insulin-like growth factor (IGF)-binding protein (IGFBP) family. IGFBPs bind IGFs with high affinity, and regulate IGF availability in body fluids and tissues and modulate IGF binding to its receptors. This protein binds IGF-I and IGF-II with relatively low affinity, and belongs to a subfamily of low-affinity IGFBPs. It also stimulates prostacyclin production and cell adhesion. Alternatively spliced transcript variants encoding different isoforms have been described for this gene, and one variant has been associated with retinal arterial macroaneurysm.

References:

1. Oh Y, et al. (1996) J Biol Chem. 271(48):30322-5. 2.Akaogi K, et al. (1994) Biochem Biophys Res Commun. 198(3):1046-53.